Real-time enrollment status for this metabolic dysfunction-associated steatohepatitis clinical trial
Current Status
Recruiting
Checked: November 6, 2026 at 10:43 AM UTC
| NCT Number | NCT07701993 |
| Recruiting Status | Recruiting |
| Condition | Metabolic Dysfunction-associated Steatohepatitis |
| Phase | PHASE3 |
| Target Enrollment | 1,740 participants |
| Active Locations | 28 sites in the US |
| Sponsor | GlaxoSmithKline |
| Last Updated on CT.gov | November 5, 2026 (Yesterday) |
As of November 6, 2026: Clinical trial NCT07701993 is currently recruiting participants. This phase3 study for metabolic dysfunction-associated steatohepatitis is actively seeking new participants at 28 locations across the United States. The study is sponsored by GlaxoSmithKline. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07701993 is actively recruiting participants as of November 6, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 28 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07701993 was last updated Yesterday (November 5, 2026). HelloStudys verifies this status automatically.